Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Molecules ; 28(20)2023 Oct 17.
Article in English | MEDLINE | ID: mdl-37894610

ABSTRACT

Angiotensin-converting enzyme 1 (ACE1) is a peptide involved in fluid and blood pressure management. It regulates blood pressure by converting angiotensin I to angiotensin II, which has vasoconstrictive effects. Previous studies have shown that certain compounds of natural origin can inhibit the activity of angiotensin-converting enzymes and exert blood pressure-regulating effects. Surface Plasmon Resonance (SPR) biosensor technology is the industry standard method for observing biomolecule interactions. In our study, we used molecular simulation methods to investigate the docking energies of various herbal metabolites with ACE1 proteins, tested the real-time binding affinities between various herbal metabolites and sACE1 by SPR, and analyzed the relationship between real-time binding affinity and docking energy. In addition, to further explore the connection between inhibitor activity and real-time binding affinity, several herbal metabolites' in vitro inhibitory activities were tested using an ACE1 activity test kit. The molecular docking simulation technique's results and the real-time affinity tested by the SPR technique were found to be negatively correlated, and the virtual docking technique still has some drawbacks as a tool for forecasting proteins' affinities to the metabolites of Chinese herbal metabolites. There may be a positive correlation between the enzyme inhibitory activity and the real-time affinity detected by the SPR technique, and the results from the SPR technique may provide convincing evidence to prove the interaction between herbal metabolites and ACE1 target proteins.


Subject(s)
Angiotensin-Converting Enzyme Inhibitors , Biosensing Techniques , Angiotensin-Converting Enzyme Inhibitors/pharmacology , Angiotensin-Converting Enzyme Inhibitors/chemistry , Molecular Docking Simulation , Surface Plasmon Resonance , Biosensing Techniques/methods , Angiotensins
2.
Biosci Rep ; 41(6)2021 06 25.
Article in English | MEDLINE | ID: mdl-34036306

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Gualou Xiebai Banxia (GLXBBX) decoction is a well-known traditional Chinese herbal formula that was first discussed in the Synopsis of the Golden Chamber by Zhang Zhongjing in the Eastern Han Dynasty. In traditional Chinese medicine, GLXBBX is commonly prescribed to treat cardiovascular diseases, such as coronary heart disease and atherosclerosis. OBJECTIVE: The present study aimed to examine GLXBBX's preventative capacity and elucidate the potential molecular mechanism of Poloxamer 407 (P407)-induced hyperlipidemia in rats. MATERIALS AND METHODS: Both the control and model groups received pure water, and the test group also received a GLXBBX decoction. For each administration, 3 ml of the solution was administered orally. To establish hyperlipidemia, a solution mixed with 0.25 g/kg P407 dissolved in 0.9% normal saline was injected slowly into the abdominal cavity. At the end of the study, the rats' plasma lipid levels were calculated using an automatic biochemical analyzer to evaluate the preventative capability of the GLXBBX decoction, and the serum and liver of the rats were collected. RESULTS: The GLXBBX decoction significantly improved P407-induced hyperlipidemia, including increased plasma triglycerides (TGs), aspartate aminotransferase (AST) elevation, and lipid accumulation. Moreover, GLXBBX decoction treatment increased lipoprotein lipase (LPL) activity and mRNA expression of LPL. Furthermore, GLXBBX significantly suppressed the mRNA expression of stearoyl-CoA desaturase (SCD1). CONCLUSION: GLXBBX significantly improved P407-induced hyperlipidemia, which may have been related to enhanced LPL activity, increased LPL mRNA expression, and decreased mRNA expression of SCD1.


Subject(s)
Drugs, Chinese Herbal/pharmacology , Hyperlipidemias/prevention & control , Hypolipidemic Agents/pharmacology , Lipids/blood , Animals , Biomarkers/blood , Disease Models, Animal , Hyperlipidemias/blood , Hyperlipidemias/chemically induced , Lipoprotein Lipase/genetics , Lipoprotein Lipase/metabolism , Male , Poloxamer , Rats, Wistar , Stearoyl-CoA Desaturase/genetics , Stearoyl-CoA Desaturase/metabolism
3.
Br J Nutr ; 115(5): 807-16, 2016 Mar 14.
Article in English | MEDLINE | ID: mdl-26811108

ABSTRACT

The effect of Zn, as an adjunct to antibiotics, on the treatment of severe pneumonia in young children is still under debate; therefore, we performed a meta-analysis to evaluate the therapeutic role of Zn for severe pneumonia in children younger than 5 years. PubMed, Cochrane library and Embase databases were systematically searched from inception until October 2015 for randomised-controlled trials (RCT) that assessed the effect of Zn as an adjunct to antibiotics for severe pneumonia. Random-effects model was used for calculating the pooled estimates, and intention-to-treat principle was also applied. Nine RCT involving 2926 children were included. Overall, the pooled results showed that adjunct treatment with Zn failed to reduce the time to recovery from severe pneumonia (hazard ratios (HR)=1·04; 95% CI 0·90, 1·19; I(2)=39%; P=0·58), hospital length of stay (HR=1·04; 95% CI 0·83, 1·33; I(2)=57%; P=0·74), treatment failure (relative risk (RR)=0·95; 95% CI 0·79, 1·14; I(2)=20%; P=0·58) or change of antibiotics (RR=1·07; 95% CI 0·79, 1·45; I(2)=44%; P=0·67). In addition, continuous outcomes were consistent while meta-analysed with standard mean difference, and all outcomes remained stable in intention-to-treat analysis. No significant differences were observed in the two groups between death rate, adverse events or recovery times of severe pneumonia indicators. Our results suggested that adjunct treatment with Zn failed to benefit young children in the treatment of severe pneumonia. Considering the clinical heterogeneity, baseline characteristics of children, definition of severe pneumonia and Zn supplement way should be taken into consideration in future research. This study was registered at PRESPERO as CRD42015019798.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Pneumonia/drug therapy , Zinc/therapeutic use , Child, Preschool , Dietary Supplements , Female , Humans , Male , Randomized Controlled Trials as Topic , Treatment Outcome
4.
Ying Yong Sheng Tai Xue Bao ; 20(7): 1597-602, 2009 Jul.
Article in Chinese | MEDLINE | ID: mdl-19899457

ABSTRACT

A field experiment was conducted to study the effects of maize/peanut intercropping on the rhizosphere soil microbial community and nutrient contents. Three treatments were installed, i. e., maize/peanut intercropping, maize monoculture, and peanut monoculture. Comparing with monoculture, intercropping could significantly increase the quantity of soil bacteria in both maize and peanut root areas. The numbers of soil actinomyces and fungi had no significant differences in the root areas of intercropped and mono-cultured peanut, but were much higher in intercropped than in mono-cultured maize root area. The functional diversity and metabolic activity of soil microbial community also improved under intercropping. Maize/peanut intercropping increased the soil alkali-hydrolysable N, available P and organic matter contents and EC to some extent, especially in the root area of maize. All the results suggested that maize/peanut intercropping could obviously improve the status of soil microbes and nutrients in root areas, which in turn, would promote the growth of intercropped crops.


Subject(s)
Agriculture/methods , Arachis/genetics , Soil Microbiology , Soil/analysis , Zea mays/growth & development , Arachis/metabolism , Nitrogen/analysis , Organic Chemicals/analysis , Phosphorus/analysis , Plant Roots/metabolism , Zea mays/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL